Late-onset clozapine-induced neutropenia treated with lithium
Küçük Resim Yok
Tarih
2019
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Yerkure Tanitim & Yayincilik Hizmetleri A S
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Clozapine is a second-generation antipsychotic drug, proven to be effective in treatment-resistant schizophrenia. Among patients using clozapine; the incidence of neutropenia is approximately 3% and the incidence of agranulocytosis is approximately 1%. This side effect is diminishing after 18 weeks of drug initiation. Here, we present a case of clozapine-induced neutropenia in a schizophrenic patient seen after 7 years of clozapine use and its treatment with lithium supplementation.
Açıklama
Anahtar Kelimeler
Clozapine, Lithium, Neutropenia, Colony-Stimulating Factor, Continuing Clozapine, Rechallenge, Agranulocytosis, Leukopenia
Kaynak
Dusunen Adam-Journal Of Psychiatry And Neurological Sciences
WoS Q Değeri
N/A
Scopus Q Değeri
Q3
Cilt
32
Sayı
1
